Watch Ticker

Structure Therapeutics Inc. American Depositary Shares

Go to Structure Therapeutics Inc. American Depositary Shares Website

$0.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.8 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and bi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Structure Therapeutics Inc. - Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that Raymond Stevens, Ph.D., the Company’s Founder and Chief Executive Officer, will participate in a fireside chat at the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024, at 8:00 AM ET in Miami, Florida.

Related tickers: GPCR.

Read Full Article

Structure Therapeutics Inc. - Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

Topline GSBR-1290 Phase 2a 12-week obesity data, as well as data from formulation bridging and titration optimization study, on track for latter half of the second quarter 2024

Related tickers: GPCR.

Read Full Article

Trending Tickers

LASE

XNAS

$2.04

(%)

PACW

XNAS

$7.54

(%)

SMFL

XNAS

$3.58

(%)

XNYS

$69.47

(%)

MLGO

XNAS

$0.00

(%)